FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sinografin Injection Solution (Diatrizoate Meglumine)(Iodipamide Meglumine)
Status: Discontinuation
»Therapeutic Categories: Medical Imaging

Bracco Diagnostics (New 01/04/2018)

Company Contact Information:
877-272-2269

Presentation Posting Date Related Information
52.7% diatrizoate meglumine; 26.8% iodipamide meglumine 10 x 10 mL per single dose vial (NDC 0270-0523-30) 01/04/2018 Discontinuation of the manufacture of the drug product is due to business reasons.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English